SI-BONE, Inc. Appoints Karen Licitra and Keith Valentine to its Board of Directors

SAN JOSE, Calif., Sept. 1, 2015 /PRNewswire/ — SI-BONE, Inc., a medical device company that pioneered the use of the iFuse Implant System®, a minimally invasive surgical (MIS) device
indicated for fusion for certain disorders of the sacroiliac (SI) joint, announced that Karen Licitra and Keith Valentine have been appointed to its Board of Directors.

Ms. Licitra was recently Corporate Vice President at Johnson & Johnson where she led Worldwide Government Affairs & Policy. In this role, she was responsible for Johnson & Johnson’s engagements with global government leaders at the multilateral, national and state levels. Her organization also led development of Johnson & Johnson public policy. Previously, Karen was Worldwide Chairman of the Global Medical Solutions Group within Johnson & Johnson’s Medical Device and Diagnostics segment. In that role, she was responsible for establishing the strategy and vision for an $8 billion global portfolio of healthcare companies including Vision Care, Diabetes Care, Ortho Clinical Diagnostics, and Advanced Sterilization Products, as well as the Sedation business unit. She was named to Fortune’s 50 Most Powerful Women in Business list in 2012.

Mr. Valentine is currently President and Chief Executive Officer of SeaSpine Holdings Corporation, a medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. Prior to joining SeaSpine, Mr. Valentine served as President and Chief Operating Officer of NuVasive, Inc. from January 2007 to January 2015 and as President from December 2004 to January 2007, prior to which he served in various senior executive roles in Marketing, Development and Operations after joining NuVasive in 2001. Previously, Mr. Valentine held executive positions at ORATEC that was acquired by Smith & Nephew PLC, and spent eight years in various senior roles with Medtronic Sofamor Danek.

“We are extremely pleased and honored to have both Karen and Keith join our Board of Directors simultaneously. Individually, they have each built distinguished careers that span decades of impressive leadership and accomplishments, and both are highly respected in the medical device industry. We look forward to their guidance and contribution as SI-BONE moves into our next phase of growth,” said Jeffrey Dunn, President and CEO of SI-BONE.

“I am thrilled to be joining an organization that so highly values clinical evidence and is focused on improving patients’ lives,” said Ms. Licitra. “I look forward to contributing to SI-BONE’s ongoing success and commercial efforts.”

“I am pleased to join SI-BONE’s Board of Directors, and look forward to working with the Board and team to help execute on a solid strategy as the company continues to grow and build out its business,” said Mr. Valentine.

About SI-BONE, Inc.